MMRF Accelerator Magazine Summer 2016 Edition | Page 15

Without participation from patients, families Patients have hope. and other supporters, no research would be possible. Data has answers. of their disease journey. We’ve learned that those clinical grade sequencing that treatments for multiple myeloma results get delivered quickly, which is are as individual as the genomic important for patients who are out of makeup of patients. And we believe that options and short on time. precision medicine’s time has come. Funding is essential. Please give now. We know that answers “There is more hope now than ever.” lie in patients’ data. Finding Clinical studies can now provide them requires funding. actionable information during the time The MMRF is bringing academia, they are being conducted, especially industry and clinicians together in a long-term one like the MMRF to analyze data that’s critical to CoMMpass Study. We have developing personalized treatments. implemented best-in-class standards While this time in history is truly a that empower clinicians and patients turning point, our efforts will yield Please give now, when our life-saving to make fully informed decisions by more treatments and, ultimately, cures work is more promising than ever. providing genomic sequencing that only if we maintain and build on our Our supporters’ generosity has helped employs the highest standard of momentum. There is still so much to be us come this far. Working together is accuracy. And we have made certain done. There is no room for complacency. essential to bringing patients the right The one essential component to our treatments and finding a cure. Please success is your support. donate today! This is the kind of quote that inspires us: “The MMRF does so much for us and I am living proof. I am so grateful!” ­— Amy Webb, multiple myeloma patient, with her daughter Heather We hope it inspires you, too. Give today. M M RF I N T H E N E W S themmrf.org/donatenow